Search clinical trials for: aromatase Inhibitors (AIs)

Total 67024 results

NRG Oncology
National Cancer Institute (NCI)

Recruiting

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

Breast Cancer

United States, Puerto Rico
Prof. Wolfgang Janni
Eli Lilly and Company

Recruiting

Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management (MINERVA)

Hormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast Cancer

Germany, Switzerland
Intermountain Health Care, Inc.

Completed

Test of Chamber Pressure to Divers and Chamber Attendants (TOP-DIVER)

Traumatic Brain Injury

United States
Consorzio Oncotech

Unknown

Overcoming Endocrine Resistance in Metastatic Breast Cancer (OVER)

Metastatic Breast Cancer

Italy
Pfizer

Completed

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy (TAMARA)

Breast Neoplasms

Turkey
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC (CAPACITY)

Hormone Receptor Positive Advanced Breast Cancer

China
Monica Mita
Cedars-Sinai Medical Center

Terminated

NEOBREADS: Neoadjuvant Breast Diet Study (NEOBREADS)

Breast Cancer

United States
Farin Amersi

Terminated

BREADS: Breast Adjuvant Diet Study

Breast Cancer

United States
Nik Hazlina

Completed

The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)

Polycystic Ovarian Syndrome
International Cancer Research Group, United Arab...
King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaborators

Recruiting

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. (ICRG0201)

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

Algeria, Jordan, Saudi Arabia
British Columbia Cancer Agency
Janssen Research & Development, LLC

Withdrawn

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer

Canada
Rigshospitalet, Denmark

Completed

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Infertility

Denmark
Tvardi Therapeutics, Incorporated

Active, not recruiting

Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

Breast Cancer

United States
Pfizer

Completed

Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region

Breast Neoplasms

Qatar, United Arab Emirates, Saudi Arabia
Dharmais National Cancer Center Hospital

Completed

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Breast Cancer

Indonesia
Sohag University

Recruiting

Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases

Poly Cystic Ovary Treatment for Infertility

Egypt
Tianjin Medical University

Unknown

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer (esozao)

Breast Cancer

China
Pfizer

Active, not recruiting

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

Breast Cancer

United States
Minia University

Completed

Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI (AIPRICSI)

Infertility Indicated for ICSI

Egypt
University of Alabama, Tuscaloosa
University of Alabama at Birmingham

Recruiting

Improving Access and Affordability of Adult Hearing Healthcare

Hearing Loss

United States
Chia-hsi Chen

Active, not recruiting

AIS and START Grade With Films Transferring in Disaster Management (START)

Trauma | Disaster

Taiwan
Eli Lilly and Company

Active, not recruiting

A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer (EMBER)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial Cancer

United States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
University of Southern Denmark

Recruiting

Benefits From Bimodal Fittings With Cochlear Implant and Hearing Aid vs Bilateral Hearing Aids

Hearing Loss, Cochlear

Denmark
Sun Yat-sen University

Active, not recruiting

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (MECCA)

Breast Cancer

China
Hoffmann-La Roche

Completed

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (PERTAIN)

Breast Cancer

United States, United Kingdom, France, Italy, Spain, Turkey, Brazil, India
Centre for Endocrinology and Reproductive Medicine...

Active, not recruiting

Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis

Uterine Adenomyosis | Recurrent Implantation Failure | Menstrual Pain

Bulgaria, Italy, Albania
Xu fei
Sun Yat-sen University

Unknown

Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer (BETTER)

Breast Cancer

China
VA Office of Research and Development

Not yet recruiting

Self-Management Program for AIS D SCI (SCISM-D)

Spinal Cord Injuries | Psychological Well-Being

United States
Cynthia Harris
SurgiQuest, Inc.

Completed

Pneumoperitoneum Management With SurgiQuest AirSeal at Low vs. Higher Pressure ( PRESSURE ) (PRESSURE)

Shoulder Pain

United States
Thomas Hatschek

Active, not recruiting

Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases (PREDIX LumB)

Early-Stage Breast Carcinoma | Estrogen Receptor Positive Tumor

Sweden
Monash University

Completed

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

Arthralgia

Australia
Massachusetts General Hospital
Genentech, Inc.

Active, not recruiting

AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

Breast Cancer

United States
Peking Union Medical College Hospital

Not yet recruiting

Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC (Pyrotinib)

Breast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
Fudan University
Chongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaborators

Recruiting

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor

China
Hoffmann-La Roche

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

United States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
British Columbia Cancer Agency
Canadian Cancer Society (CCS); NanoString Technologies, Inc.

Active, not recruiting

Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer (LALEAST)

Breast Cancer Female | Hormone Receptor Positive Tumor

Canada
Baylor Breast Care Center

Withdrawn

Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer (AIA)

Breast Cancer | Joint Pain | Arthralgia
Fudan University

Recruiting

Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer (BCTOP-L-M01)

Breast Cancer | Advanced Breast Cancer

China
Loyola University

Completed

Surgical Pain Control With Ropivacaine by Atomized Delivery (SPRAY)

Pain

United States
Vanderbilt University Medical Center
American Cancer Society, Inc.; National Center for Research Resources (NCRR)

Completed

Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors

Breast Cancer | Arthralgia

United States
Indiana University

Terminated

PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Amgen
Austrian Breast and Colorectal Cancer Study Group

Completed

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Breast Cancer

Austria, Sweden
Medical College of Wisconsin

Not yet recruiting

Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Breast Cancer

United States
Yongsheng Wang
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Locally Advanced Breast Cancer | Hormone Receptor Positive，HER2-negative Breast Cancer

China
Borstkanker Onderzoek Groep

Active, not recruiting

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Breast Neoplasm Female

Netherlands
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)

Withdrawn

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in Situ

United States, Canada
Rahem Fertility Center

Completed

The Outcome of Two Protocols Used to Prepare Endometrium for Frozen Embryo Transfer

Infertility | Infertility, Female | Infertility, Male

Egypt
Massachusetts General Hospital
National Institutes of Health (NIH)

Unknown

Letrozole Treatment in Normal and GnRH Deficient Women

Healthy Volunteers

United States
Canadian Cancer Trials Group
Pfizer

Completed

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

Breast Cancer

Canada

Search clinical trials for: aromatase Inhibitors (AIs)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations